Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Stock Information for Solid Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.